Samvardhana Motherson International Limited

rs,

MUMBAI – 400051, India BSE Limited 1st Floor, New Trading Ring Rotunda Building P.J. Towers, Dalal Street Fort MUMBAI – 400001, India Scrip Code : MOTHERSON Scrip Code : 517334 Subje

472 million

mber 22 due to a failed operational and financial restructuring. The group had a turnover of EUR 472 million in CY22. No b) Whether the acquisition would fall within related party transaction(s) and whe

0.5x

, working on the mobility of the future  Attractive Valuation with price to book of less than 0.5x e) Brief details of any governmental or regulatory approvals required for the acquisitions An

118.3 million

tion or the price at which the shares are acquired Overall Enterprise Value of approximately EUR 118.3 million subject to certain customary adjustments and Sr. no. Details of Events th

69.1 million

cant information (in brief) in which date actualizations  Estimated Enterprise Value of EUR 69.1 million for assets purchased in Germany subject to certain actualisations.  Estimated Enterprise Value

49.2 million

sets purchased in Germany subject to certain actualisations.  Estimated Enterprise Value of EUR 49.2 million for shares of overseas subsidiaries Overall Equity value is expected to be in the range of EUR

80 Million

shares of overseas subsidiaries Overall Equity value is expected to be in the range of EUR 70-80 Million along with financial debt of not more than EUR 20 Million. Target Business includes:  Ident

20 Million

s expected to be in the range of EUR 70-80 Million along with financial debt of not more than EUR 20 Million. Target Business includes:  Identified assets like fixed assets, intangible assets, Invento

100%

ike fixed assets, intangible assets, Inventory and certain employee in Germany liabilities  100% shares of subsidiary in Spain, China, USA and Poland  21% shareholding in Symbiose SAS, France

21%

oyee in Germany liabilities  100% shares of subsidiary in Spain, China, USA and Poland  21% shareholding in Symbiose SAS, France subject to receipt of approval from majority shareholders D

90%

e company has strong focus on R&D and product innovation, resulting in over 200 patents. More than 90% of its products have been developed in-house by a dedicated team of 240+ engineers, operating out

118.3 million

nents and can offer these The overall enterprise value of this transaction is approximately EUR 118.3 million subject to certain actualisation. This acquisition is done at the behest of our customers. The dea

“Details of Events that need to be provided a) Name of target entity, details in brief such as size, turnover etc.”

“Schneider Holding GmbH (“Target Business/ Dr Schneider Group“).”

“If yes, nature of interest and details thereof and whether the same is done at arms length c) Industry to which the entity being Automotive Industry acquired belongs d) Objects and effects of acquisition (including but not to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the Company); limited  Customers support the acquisition and subsequent term reorganization which will drive competitiveness.”

“the automotive for Due to the convergence of several macro headwinds occurring in rapid succession, such as the supply chain bottlenecks, COVID-19, energy crisis, soaring inflation, and the Ukraine conflict, along with delays in price revisions, the Target Business underwent financial distress.”

“With their continued support we believe we will be able to turnaround this business like we have done every time in the past.”

“Schneider Holding GmbH (“Target Business”) 22 * Assets of German entities acquired at an estimated purchase price of EUR 69.1 million subject to certain actualizations; 100% stake in the foreign subsidiaries of Dr.”

“• Due to the convergence of several macro headwinds occurring in rapid succession, such as the supply chain bottlenecks, COVID-19, energy crisis, soaring inflation, and the Ukraine conflict, along with delays in price revisions, the Target Business underwent financial distress.”

Regd Office

1

Target Business includes

1

Regd Office

Unit – 705, C Wing, ONE BKC, G Block Bandra Kurla Complex, Bandra East Mumbai – 400051, Maharashtra (India) Tel: 022-61354800, Fax: 022-61354801 CIN No.: L34300MH1986PLC284510 Email: investorrelations@motherson.com Acquisition (including agreement to acquire) ANNEXURE A Sr. no. Details of Events that need to be provided a) Name of target entity, details in brief such as size, turnover etc. Information about such events Assets of the German entities of Dr. Schneider Holding GmbH and shares in the foreign subsidiaries of Dr. Schneider Holding GmbH (“Target Business/ Dr Schneider Group“). Dr. Schneider Group is a manufacturer of innovative, high-end interior components with global technology offerings, who filed for insolvency in September 22 due to a failed operational and financial restructuring. The group had a turnover of EUR 472 million in CY22. No b) Whether the acquisition would fall within related party transaction(s) and whether the promoter/promoter group/ group companies have a

Target Business includes

 Identified assets like fixed assets, intangible assets, Inventory and certain employee in Germany liabilities  100% shares of subsidiary in Spain, China, USA and Poland  21% shareholding in Symbiose SAS, France subject to receipt of approval from majority shareholders Dr. Schneider Group was founded in 1927. In 1936, the company started manufacturing plastic components for the automotive and other allied industries. Dr. Schneider Group is a manufacturer of innovative, high-end integrated electronic interior components with global technology offerings. The Company has grown to 7 facilities across 5 countries with ~4,500 employees manufacturing various interior components industry, especially in the premium segment. the automotive for Due to the convergence of several macro headwinds occurring in rapid succession, such as the supply chain bottlenecks, COVID-19, energy crisis, soaring inflation, and the Ukraine conflict, along with delays in price revisions, the Target Business underw